KİMYON, G. Et Al. 2018. Leflunomide As a Concomitant DMARD Choice for the Biological Treatment Era of Rheumatoid Arthritis. ACR/ARHP Annual Meeting, 2018 , (Chicago, United States Of America), 586-587.

KİMYON, G., KİRAZ, S., ERTENLİ, A. İ., KÜÇÜKŞAHİN, O., DALKILIÇ, H. E., BES, C., ... ALPAY KANITEZ, N.(2018). Leflunomide As a Concomitant DMARD Choice for the Biological Treatment Era of Rheumatoid Arthritis . ACR/ARHP Annual Meeting, 2018 (pp.586-587). Chicago, United States Of America

KİMYON, GEZMİŞ Et Al. "Leflunomide As a Concomitant DMARD Choice for the Biological Treatment Era of Rheumatoid Arthritis," ACR/ARHP Annual Meeting, 2018, Chicago, United States Of America, 2018

KİMYON, GEZMİŞ Et Al. "Leflunomide As a Concomitant DMARD Choice for the Biological Treatment Era of Rheumatoid Arthritis." ACR/ARHP Annual Meeting, 2018 , Chicago, United States Of America, pp.586-587, 2018

KİMYON, G. Et Al. (2018) . "Leflunomide As a Concomitant DMARD Choice for the Biological Treatment Era of Rheumatoid Arthritis." ACR/ARHP Annual Meeting, 2018 , Chicago, United States Of America, pp.586-587.

@conferencepaper{conferencepaper, author={GEZMİŞ KİMYON Et Al. }, title={Leflunomide As a Concomitant DMARD Choice for the Biological Treatment Era of Rheumatoid Arthritis}, congress name={ACR/ARHP Annual Meeting, 2018}, city={Chicago}, country={United States Of America}, year={2018}, pages={586-587} }